FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080483953> ?p ?o ?g. }

• W2080483953 endingPage "350" @default.
• W2080483953 startingPage "343" @default.
• W2080483953 abstract "To report the clinicopathologic findings after submacular removal of choroidal neovascular membranes (CNV) treated with verteporfin ocular photodynamic therapy.Interventional case series.Retrospective review of eight eyes of eight patients who underwent submacular surgery for CNV after having previously received verteporfin ocular photodynamic therapy for presumed ocular histoplasmosis (one patient), age-related macular degeneration ([AMD] three patients) pathologic myopia (two patients), punctate inner choroiditis (one patient), and idiopathic CNV (one patient). All cases had undergone ocular photodynamic therapy with verteporfin using standard protocols. Six of eight patients suffered a submacular hemorrhage after ocular photodynamic therapy, and two of eight patients refused further ocular photodynamic therapy. All patients subsequently had submacular surgery with removal of the CNV. One membrane was routinely processed, sectioned, and stained with hematoxylin and eosin. Five membranes were stained with toluidine blue for light microscopic examination. Semithin (1.0 microm) sections were cut and stained with uranyl acetate-lead citrate for transmission electron microscopy.Choroidal neovascular membranes were removed at 3 days (presumed ocular histoplasmosis), 29 days (punctate inner choroiditis), 63 days (AMD, pathologic myopia), 66 days (AMD), 107 days (pathologic myopia), 116 days (AMD), and 152 days (idiopathic) after verteporfin ocular photodynamic therapy. Histopathologic and ultrastructural examination showed areas of vascular occlusion at 3 days that were not seen at later time points. All specimens had patent CNV. There were signs of vascular damage with extravasated erythrocytes and fibrin, pigment clumping in cells, and inflammatory cells in all but the 3-day specimen.This case series presents data only from patients who refused repeat treatment with ocular photodynamic therapy or who developed submacular hemorrhage after initial photodynamic therapy. Histopathologic evaluation of CNV 3 days after verteporfin ocular photodynamic therapy showed partial vascular occlusion that was not present in later specimens. These later specimens demonstrated evidence of vascular damage. Verteporfin ocular photodynamic therapy does not appear to lead to permanent and complete occlusion of the CNV. Thus, treatments that lead to permanent closure of CNV without damage to the retinal pigment epithelium and sensory retina are still needed." @default.
• W2080483953 created "2016-06-24" @default.
• W2080483953 creator A5008156324 @default.
• W2080483953 creator A5036626486 @default.
• W2080483953 creator A5046713073 @default.
• W2080483953 creator A5052574764 @default.
• W2080483953 creator A5055166338 @default.
• W2080483953 creator A5057277785 @default.
• W2080483953 creator A5065472530 @default.
• W2080483953 creator A5071115321 @default.
• W2080483953 creator A5073337092 @default.
• W2080483953 creator A5087286807 @default.
• W2080483953 date "2003-03-01" @default.
• W2080483953 modified "2023-09-24" @default.
• W2080483953 title "Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy" @default.
• W2080483953 cites W1580014443 @default.
• W2080483953 cites W1581243243 @default.
• W2080483953 cites W1601975653 @default.
• W2080483953 cites W1966167046 @default.
• W2080483953 cites W1974903672 @default.
• W2080483953 cites W1981700240 @default.
• W2080483953 cites W2037621047 @default.
• W2080483953 cites W2046395554 @default.
• W2080483953 cites W2053911275 @default.
• W2080483953 cites W2058266372 @default.
• W2080483953 cites W2079934342 @default.
• W2080483953 cites W2110960237 @default.
• W2080483953 cites W2114900908 @default.
• W2080483953 cites W2133251726 @default.
• W2080483953 cites W2152029720 @default.
• W2080483953 cites W2152699331 @default.
• W2080483953 cites W233579014 @default.
• W2080483953 cites W4242893149 @default.
• W2080483953 cites W4243337108 @default.
• W2080483953 cites W945208301 @default.
• W2080483953 doi "https://doi.org/10.1016/s0002-9394(02)01936-0" @default.
• W2080483953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12614752" @default.
• W2080483953 hasPublicationYear "2003" @default.
• W2080483953 type Work @default.
• W2080483953 sameAs 2080483953 @default.
• W2080483953 citedByCount "62" @default.
• W2080483953 countsByYear W20804839532012 @default.
• W2080483953 countsByYear W20804839532013 @default.
• W2080483953 countsByYear W20804839532014 @default.
• W2080483953 countsByYear W20804839532015 @default.
• W2080483953 countsByYear W20804839532017 @default.
• W2080483953 countsByYear W20804839532019 @default.
• W2080483953 countsByYear W20804839532023 @default.
• W2080483953 crossrefType "journal-article" @default.
• W2080483953 hasAuthorship W2080483953A5008156324 @default.
• W2080483953 hasAuthorship W2080483953A5036626486 @default.
• W2080483953 hasAuthorship W2080483953A5046713073 @default.
• W2080483953 hasAuthorship W2080483953A5052574764 @default.
• W2080483953 hasAuthorship W2080483953A5055166338 @default.
• W2080483953 hasAuthorship W2080483953A5057277785 @default.
• W2080483953 hasAuthorship W2080483953A5065472530 @default.
• W2080483953 hasAuthorship W2080483953A5071115321 @default.
• W2080483953 hasAuthorship W2080483953A5073337092 @default.
• W2080483953 hasAuthorship W2080483953A5087286807 @default.
• W2080483953 hasConcept C118487528 @default.
• W2080483953 hasConcept C120665830 @default.
• W2080483953 hasConcept C121332964 @default.
• W2080483953 hasConcept C141071460 @default.
• W2080483953 hasConcept C178790620 @default.
• W2080483953 hasConcept C185592680 @default.
• W2080483953 hasConcept C2776403814 @default.
• W2080483953 hasConcept C2776694393 @default.
• W2080483953 hasConcept C2777093970 @default.
• W2080483953 hasConcept C2778784831 @default.
• W2080483953 hasConcept C2781148688 @default.
• W2080483953 hasConcept C2781323092 @default.
• W2080483953 hasConcept C2781359195 @default.
• W2080483953 hasConcept C2911002200 @default.
• W2080483953 hasConcept C71924100 @default.
• W2080483953 hasConceptScore W2080483953C118487528 @default.
• W2080483953 hasConceptScore W2080483953C120665830 @default.
• W2080483953 hasConceptScore W2080483953C121332964 @default.
• W2080483953 hasConceptScore W2080483953C141071460 @default.
• W2080483953 hasConceptScore W2080483953C178790620 @default.
• W2080483953 hasConceptScore W2080483953C185592680 @default.
• W2080483953 hasConceptScore W2080483953C2776403814 @default.
• W2080483953 hasConceptScore W2080483953C2776694393 @default.
• W2080483953 hasConceptScore W2080483953C2777093970 @default.
• W2080483953 hasConceptScore W2080483953C2778784831 @default.
• W2080483953 hasConceptScore W2080483953C2781148688 @default.
• W2080483953 hasConceptScore W2080483953C2781323092 @default.
• W2080483953 hasConceptScore W2080483953C2781359195 @default.
• W2080483953 hasConceptScore W2080483953C2911002200 @default.
• W2080483953 hasConceptScore W2080483953C71924100 @default.
• W2080483953 hasIssue "3" @default.
• W2080483953 hasLocation W20804839531 @default.
• W2080483953 hasLocation W20804839532 @default.
• W2080483953 hasOpenAccess W2080483953 @default.
• W2080483953 hasPrimaryLocation W20804839531 @default.
• W2080483953 hasRelatedWork W1863614537 @default.
• W2080483953 hasRelatedWork W1985479513 @default.
• W2080483953 hasRelatedWork W2033066615 @default.
• W2080483953 hasRelatedWork W2077460937 @default.

• next